SCHEMBL1373704

SCHEMBL1373704

[CH2]N1CCC(C(=O)OC(C)(C)C)C1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.48
HPGD P15428 1/20 0.41
RECQL P46063 1/20 0.39
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
PTPN6 P29350 1/20 0.35
CTSK P43235 2/20 0.35
MAPT P10636 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
STS P08842 6/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5023573 0.89 HRH3 (0.54) HRH3HPGDRECQLMEN1ALDH1A1
SCHEMBL2475032 0.80 HRH3 (0.49) HRH3HPGDRECQLMEN1ALDH1A1
SCHEMBL1373706 0.80 HRH3 (0.49) HRH3HPGDRECQLMEN1ALDH1A1
SCHEMBL20463446 0.80 HRH3 (0.49) HRH3HPGDRECQLMEN1ALDH1A1
Formaldehyde SCHEMBL9013379 0.79 HRH3 (0.46) HRH3HPGDRECQLMEN1ALDH1A1
SCHEMBL1852285 0.79 HRH3 (0.48) HRH3HPGDRECQLMEN1ALDH1A1
SCHEMBL15919660 0.79 HRH3 (0.48) HRH3HPGDRECQLMEN1ALDH1A1
SCHEMBL183835 0.79 HRH3 (0.48) HRH3HPGDRECQLMEN1ALDH1A1
SCHEMBL222318 0.79 HRH3 (0.48) HRH3HPGDRECQLMEN1ALDH1A1
SCHEMBL750380 0.77 HRH3 (0.54) HRH3HPGDRECQLMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791102-B2 Acetanilide sphingosine-1-phosphate receptor antagonists EXELIXIS, INC. (US) 2014-07-29 US disclosed
US-20110288076-A1 Sphingosine-1-Phosphate Receptor Antagonists EXELIXIS, INC. (US) 2011-11-24 US disclosed
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed
WO-2010045580-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288076-A1 Sphingosine-1-Phosphate Receptor Antagonists S1PR1, S1PR2, S1PR3 HRH3 548/4885HPGD 3360/4885RECQL 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.